Carnevale Alessia

Born in Caserta (CE) on 25.9.1981. Degree in Medicine and Surgery at the Faculty of Medicine and Surgery 'Sapienza' University of Rome with final grade of 110/110 cum laude dated 31/3/2008. Registration in the Register of Doctors and Dentists at the Frosinone Doctors' Register. Specialist degree in Radiotherapy at the Faculty of Medicine and Psychology of the Sant' HospitalAndrea 'Sapienza' University of Rome with final grade 70/70 cum laude dated 30/6/2014.

Since 1/9/2014 Medical Director at the Department of Oncological Radiotherapy at the Campus Biomedico University Hospital in Rome. Since 1/1/2019 Member of the PDTA breast pathology as a specialist in Oncological Radiotherapy at Sandro Pertini Hospital - ASL Roma 2. Participation in various courses and conferences in the health sector, particularly in the Oncology and Radiotherapy sectors. Member of scientific societies: AIRO, AIOM, SIURO, ESTRO

1.D'Amico et al. Radiomics-based prediction of overall survival in lung cancer using different volumes-of-interest. Applied Sciences Volume 10, Issue 18, September 2020, Article number 6425.

2.18F- Choline PET/CT Driven Salvage Radiotherapy in Prostate Cancer Patients: Up-Date Analysis with 5-years Median Follow up. RM.D'Angelillo et al Radiol Med.2020 Jul;125(7):668-673.

3.Effects of ionizing radiation on bio-active plant extracts useful for preventing oxidative damage. Mulinacci N et al G.vNat Prod Res. 2018 Apr 2:1-9

4.Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).Mercadante Set at the IOPS MS study group.Adv Ther. 2017 Jan;34(1):120-135.

5.Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy. Valeriani M et al. Tumors. 2015 May-Jun;101(3):318-22. M

6.Severe and Prolonged Myelosuppression during Concomitant Temozolomide and Radiotherapy Treatment in a Patient with Glioblastoma Multiforme. Claudia Scaringi et al

7.Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients. Agolli Let al Anticancer Res. 2015 Mar;35(3):1783-9.

8. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings. Mercadante S et al; IOPS Study Group. Clin J Pain. 2015 Mar;31(3):214-21.

9.Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results. Valeriani M, Carnevale A et al. Radiat Oncol. 2014 Sep 26;9:214.

10.Image-guided hypofractionated radiotherapy in low-risk prostate cancer patients. Valeriani M, Carnevale A, et al. Biomed Res Int. 2014;2014:465175.

11.Hypofractionated intensity-modulated simultaneous integrated boost and image-guided radiotherapy in the treatment of high-risk prostate cancer patients: a preliminary report on acute toxicity. Valeriani M, Carnevale A, et al. Tumors. 2013 Jul-Aug;99(4):474-9.

12.Clinical outcomes of single dose stereotactic radiotherapy for lung metastases. Osti MF, Carnevale A, et al. Clin Lung Cancer. 2013 Nov;14(6):699-703.

13. Radiation therapy after breast reconstruction: outcomes, complications, and patient satisfaction. Carnevale A, et al. Radiol Med. 2013 Oct;118(7):1240-50.

14. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitutional experience. Osti MF, Carnevale et al RM. Anticancer Res. 2013 Mar;33(3):1229-35.